Detail
| LncRNA Name | SPRY4-IT1 |
| Synonyms | SPRY4-IT1, SPRIGHTLY |
| Region | NA Sequence |
| Ensembl | ENSG00000281881 |
| RefSeq | NR_131221 |
| Circulating | ✔ |
| Drug-resisitant | ✘ |
| Prognostic | ✘ |
| MiRNA | ✘ |
| Variant | ✘ |
| TF | ✘ |
| Methylation | ✘ |
| Cancer Name | hepatocellular carcinoma |
| ICD-0-3 | C22.0 M8170/3 |
| Methods | qPCR etc. |
| Sample | blood, cell lines (Hep-3B, HepG2, HuH-7 etc.) |
| Expression Pattern | up-regulated |
| Function Description | In the present study, we focused on the expression pattern of lncRNA SPRY4 intronic transcript 1 (SPRY4-IT1) and its clinical significance in HCC diagnostics. The levels of SPRY4-IT1 were upregulated in HCC and were associated with tumor differentiation, tumor size and tumor-node-metastasis (TNM) stage. |
| Pubmed ID | 27278245 |
| Year | 2016 |
| Title | Potential diagnostic value of lncRNA SPRY4-IT1 in hepatocellular carcinoma. |
| External Links |
| Links for SPRY4-IT1 | GenBank HGNC lncrnadb Noncode |
| Links for hepatocellular carcinoma | Omim Cosmic |
CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.